tiprankstipranks
Trending News
More News >
Sagimet Biosciences, Inc. Class A (SGMT)
:SGMT
US Market
Advertisement

Sagimet Biosciences, Inc. Class A (SGMT) Stock Statistics & Valuation Metrics

Compare
1,498 Followers

Total Valuation

Sagimet Biosciences, Inc. Class A has a market cap or net worth of $220.42M. The enterprise value is $120.07M.
Market Cap$220.42M
Enterprise Value$120.07M

Share Statistics

Sagimet Biosciences, Inc. Class A has 31,001,108 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding31,001,108
Owned by Insiders10.26%
Owned by Institutions24.17%

Financial Efficiency

Sagimet Biosciences, Inc. Class A’s return on equity (ROE) is -0.29 and return on invested capital (ROIC) is -34.92%.
Return on Equity (ROE)-0.29
Return on Assets (ROA)-0.28
Return on Invested Capital (ROIC)-34.92%
Return on Capital Employed (ROCE)-0.35
Revenue Per Employee0.00
Profits Per Employee-3.25M
Employee Count14
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Sagimet Biosciences, Inc. Class A is ―. Sagimet Biosciences, Inc. Class A’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value0.91
Price to FCF
Price to Operating Cash Flow-5.26
PEG Ratio

Income Statement

In the last 12 months, Sagimet Biosciences, Inc. Class A had revenue of 0.00 and earned -45.57M in profits. Earnings per share was -1.45.
Revenue0.00
Gross Profit0.00
Operating Income-54.45M
Pretax Income-45.57M
Net Income-45.57M
EBITDA-45.57M
Earnings Per Share (EPS)-1.45

Cash Flow

In the last 12 months, operating cash flow was -54.23M and capital expenditures 0.00, giving a free cash flow of -54.23M billion.
Operating Cash Flow-54.23M
Free Cash Flow-54.23M
Free Cash Flow per Share-1.75

Dividends & Yields

Sagimet Biosciences, Inc. Class A pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta3.46
52-Week Price Change125.71%
50-Day Moving Average8.55
200-Day Moving Average5.35
Relative Strength Index (RSI)39.46
Average Volume (3m)647.58K

Important Dates

Sagimet Biosciences, Inc. Class A upcoming earnings date is Nov 12, 2025, After Close (Confirmed).
Last Earnings DateAug 13, 2025
Next Earnings DateNov 12, 2025
Ex-Dividend Date

Financial Position

Sagimet Biosciences, Inc. Class A as a current ratio of 34.30, with Debt / Equity ratio of 0.12%
Current Ratio34.30
Quick Ratio34.30
Debt to Market Cap<0.01
Net Debt to EBITDA1.66
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Sagimet Biosciences, Inc. Class A has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Sagimet Biosciences, Inc. Class A EV to EBITDA ratio is -1.43, with an EV/FCF ratio of -1.54.
EV to Sales0.00
EV to EBITDA-1.43
EV to Free Cash Flow-1.54
EV to Operating Cash Flow-1.54

Balance Sheet

Sagimet Biosciences, Inc. Class A has $125.41M in cash and marketable securities with $152.00K in debt, giving a net cash position of -$125.25M billion.
Cash & Marketable Securities$125.41M
Total Debt$152.00K
Net Cash-$125.25M
Net Cash Per Share-$4.04
Tangible Book Value Per Share$4.97

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for Sagimet Biosciences, Inc. Class A is $32.71, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$32.71
Price Target Upside360.06% Upside
Analyst ConsensusStrong Buy
Analyst Count8
Revenue Growth Forecast-100.00%
EPS Growth Forecast-62.44%

Scores

Smart Score10
AI Score44
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis